Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiao'er Fengreqing Oral Liquid for childhood influenza
ChiCTR2300076191Phase 4Not yet recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Xiao'er Fengre Qing and oseltamivir in influenza (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Clinical recovery time. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
Xiao'er Fengre Qingoseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR2300076191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076191.